Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Long-Term Debt Issuances: 2011-2018

Historic Long-Term Debt Issuances for Capricor Therapeutics (CAPR) over the last 4 years, with Jun 2018 value amounting to -$139,140.

  • Capricor Therapeutics' Long-Term Debt Issuances fell 155.66% to -$139,140 in Q2 2018 from the same period last year, while for Jun 2018 it was $500,000, marking a year-over-year decrease of 90.00%. This contributed to the annual value of $318,160 for FY2020, which is N/A change from last year.
  • Capricor Therapeutics' Long-Term Debt Issuances amounted to -$139,140 in Q2 2018, which was down 200.00% from $139,140 recorded in Q1 2018.
  • Capricor Therapeutics' 5-year Long-Term Debt Issuances high stood at $4.7 million for Q2 2014, and its period low was -$139,140 during Q2 2018.
  • In the last 3 years, Capricor Therapeutics' Long-Term Debt Issuances had a median value of $250,000 in 2017 and averaged $750,000.
  • Data for Capricor Therapeutics' Long-Term Debt Issuances shows a maximum YoY slumped of 155.66% (in 2018) over the last 5 years.
  • Capricor Therapeutics' Long-Term Debt Issuances (Quarterly) stood at $514,177 in 2014, then reached $1.8 million in 2016, then tumbled by 87.50% to $250,000 in 2017, then tumbled by 155.66% to -$139,140 in 2018.
  • Its Long-Term Debt Issuances was -$139,140 in Q2 2018, compared to $139,140 in Q1 2018 and $250,000 in Q4 2017.